top of page
073025 Top Ocular Oncology Treatment Centers banner.png
Know Your Eyes. Trust Where You Treat Them.

Discover our curated list of specialized ocular oncology treatment centers across the U.S.

 

These leading institutions offer advanced diagnostics, innovative therapies, clinical trials, and nationally recognized ocular oncologists dedicated to treating rare eye cancers. Whether you're newly diagnosed or exploring second opinions, our guide connects you to the top centers for compassionate, cutting-edge ocular oncology care.

Bascom Palmer Eye Institute 1.jpg
Bascom Palmer Eye Institute logo.jpeg
Ocular Oncologists:
Dr. Zelia M. Correa (Director, Ocular Oncology)
Dr. Carol L. Karp
Dr. Basil Williams
Dr. Maura Di Nicola

Bascom Palmer Eye Institute is the nation’s top-ranked eye hospital, delivering world-class vision care, groundbreaking research, and leading-edge treatments. As part of the University of Miami Health System, Bascom Palmer offers expert care across all ophthalmic specialties - from cataracts and glaucoma to retina, cornea, and ocular oncology. With a legacy of innovation and compassionate service, patients from around the world trust Bascom Palmer for the highest level of eye care. See the difference - at Bascom Palmer.

Duke Eye Center 1.png
Duke Eye Center logo.jpg
Ocular Oncologists:
Dr. Miguel A. Materin, MD (Professor of Ophthalmology and Radiation Oncology)
Dr. Arpita Maniar, MBBS, MD (Ocular Oncology)

Duke Eye Center is a nationally recognized leader in eye care, research, and innovation, offering advanced treatments for a wide range of vision conditions, including rare ocular cancers.

With a patient-centered approach and access to groundbreaking clinical trials, Duke delivers expert, compassionate care designed to protect and restore sight. Their team of leading ophthalmologists, researchers, and surgeons work collaboratively to tailor treatment plans to each patient’s unique needs. As part of the Duke Health system, the Eye Center combines academic excellence with cutting-edge technology to drive progress in ocular oncology and vision preservation.

Mass Eye and Ear 1.jpg
Mass Eye and Ear logo.jpg
Ocular Oncologists:
Dr. Evangelos S. Gragoudas, MD (emeritus founder of ocular oncology at MEEI) and colleagues Peggy Chang, MD; Ivana K. Kim, MD; Michael K. Yoon, MD; Nahyoung G. Lee, MD; Shizuo Mukai, MD; Suzanne K. Freitag, MD; and Thaddeus P. Dryja, MD

Mass Eye and Ear is a leading center for advanced eye and ear care, renowned for its expertise in diagnosing and treating complex conditions, including ocular cancers. Combining cutting-edge technology with compassionate, patient-focused care, Mass Eye and Ear is dedicated to preserving and restoring vision while advancing medical research. Their team of specialists collaborates across disciplines to provide personalized treatment plans tailored to each patient’s unique needs. As a major teaching hospital affiliated with Harvard Medical School, Mass Eye and Ear is committed to pioneering innovations that improve patient outcomes and enhance quality of life.

Ocular Oncologists:
Dr. Hakan Demirci, MD and Dr. Mark W. Johnson, MD (Retina specialists for intraocular tumors), Dr. Victor M. Elner, MD, PhD and Dr. Denise S. Kim, MD (Orbit/eyelid tumors), Dr. Christine C. Nelson, MD (Orbit), Dr. Shahzad I. Mian, MD (Surface tumors), Dr. H. Kaz Soong, MD (Orbit), and Dr. Alan Sugar, MD (Orbit)

The W.K. Kellogg Eye Center at the University of Michigan is a nationally recognized leader in vision care and research, offering comprehensive services for a wide range of eye conditions, including ocular tumors. Located in Ann Arbor, the center provides advanced diagnostic capabilities and treatments for both children and adults with eye cancers, collaborating with specialists from the Rogel Comprehensive Cancer Center to deliver multidisciplinary care. Patients benefit from cutting-edge therapies, personalized treatment plans, and a commitment to preserving and restoring vision.

Kellogg Eye Center 1_edited.jpg
Kellogg Eye Center logo.png
Ocular Oncologists:
Dr. Alison H. Skalet, MD, PhD
Paul H. Casey Chair in Ocular Oncology

Casey Eye Institute at Oregon Health & Science University (OHSU) is a nationally recognized leader in ophthalmic care, research, and education, offering advanced treatment for a wide range of eye conditions, including ocular tumors. As the only ocular oncology program in Oregon, Casey provides comprehensive care for both benign and malignant eye tumors, such as choroidal melanoma, retinoblastoma, lymphoma, and conjunctival tumors. The institute's multidisciplinary team, including specialists like Dr. Alison Skalet, combines medical and surgical expertise to deliver personalized treatment plans for patients of all ages. Patients benefit from cutting-edge therapies, access to clinical trials, and a commitment to preserving and restoring vision.

Casey Eye Institute 1.jpg
Casey Eye Institute logo.png
Vanderbilt Eye Institite 1.jpg
Vanderbilt Eye Institute logo.jpg
Ocular Oncologists:
Dr. Paul A. Sternberg, Jr., MD (Professor Emeritus of Ophthalmology, former Director of Eye Institute)vumc.org. (He founded Vanderbilt’s ocular oncology program; retina colleagues currently continue the service.)

Vanderbilt Eye Institute, part of Vanderbilt University Medical Center in Nashville, TN, is a nationally ranked academic eye center uniting expert clinical care, pioneering research, and comprehensive education.

Led by nationally recognized ophthalmologists and supported by one of the highest NIH-funded research programs in the U.S., VEI provides cutting-edge diagnostics and treatments across all subspecialties, including ocular oncology. 

Vanderbilt Eye Institute individualizes care plans and offers access to promising clinical trials and innovative therapies.

Ocular Oncologists:
Dr. Tara A. McCannel, MD, PhD (Ocular Oncology, also at Doheny Eye Institute)

UCLA Stein Eye Institute is a globally recognized leader in vision care, research, and education. Established in 1966 by Jules and Doris Stein, the institute offers comprehensive ophthalmic services, including ocular oncology, delivered by a distinguished faculty of experts. 

The Ophthalmic Oncology Center, directed by Dr. Tara A. McCannel, is internationally renowned for diagnosing and treating ocular melanoma and other rare eye cancers. Equipped with genetic diagnostics, radiation oncology collaboration, and access to cutting‑edge clinical trials, with designed personalized care plans that reflect the latest scientific advances

Stein Eye Institute 1.jpg
Doheny_and_UCLA_Stein_Eye_Institute_Logo.jpg
Shiley Eye Institute 1_edited.jpg
Shiley Eye Institute logo.jpg
Ocular Oncologists:
Dr. Nathan L. Scott, MD, MPP (Chief of Division, Ocular Oncology), Dr. Michael H. Goldbaum, MD, Dr. Don O. Kikkawa, MD, FACS, and Dr. Bobby S. Korn, MD, PhD.

 

Shiley Eye Institute (UC San Diego) is San Diego’s leading academic eye center, offering full-spectrum eye care—from routine exams to advanced diagnostics, complex surgeries, and pioneering clinical treatments.

Our nationally recognized Ocular Oncology Program provides expert care for both adult and pediatric eye tumors, integrating cutting-edge imaging, plaque and systemic therapies, surgical tumor resection, and collaboration with Moores Cancer Center’s top specialists. Shiley’s world‑class physicians and surgeons deliver personalized treatment plans rooted in precision diagnostics and multidisciplinary coordination. 

Ocular Oncologists:
Dr. Gregg T. Lueder, MD (Pediatric Ophthalmology, sees eye tumors); Dr. Kisha L. Piggott, MD, PhD (Retina/Ocular Oncology)Dr. P. Kumar Rao, MD, MBA (Retina/Uveitis)

Washington University in St. Louis – John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences offers top-tier, cutting-edge eye care backed by leading research and education. As a nationally recognized academic center, they deliver comprehensive ophthalmic services including ocular oncology, cornea, glaucoma, retina, pediatric ophthalmology, and oculofacial plastic surgery. The Ocular Oncology Program provides expert diagnosis and treatment of eye tumors, such as uveal melanoma, retinoblastoma, and iris tumors. 

Washington University Ophthalmology 1.jpg
Washington University Ophthalmology logo.png
feinberg school of medicine 1.jpg
feinberg school of medicine logo.jpg
Ocular Oncologists:
Dr. Nicholas J. Volpe, MD (Pediatric Ophthalmology)
Dr. Surendra Basti, MD (Glaucoma/Neuro-Ophth)
Dr. Randy C. Bowen, MD (Retina)
Dr. Liza M. Cohen, MD (Glaucoma)
Dr. Jeremy A. Lavine, MD (Uveitis)

Northwestern University Feinberg School of Medicine’s Department of Ophthalmology is a nationally recognized academic leader in eye care, research, and education. With a patient-centered philosophy, Feinberg delivers expert, multidisciplinary treatment—from common eye conditions to complex ocular tumors—across its affiliated Northwestern Medicine facilities in Chicago. Feinberg’s ophthalmology team includes internationally recognized specialists in subspecialties spanning cornea, retina, glaucoma, uveitis, oculoplastics, pediatric ophthalmology, neuro‑ophthalmology, and ocular oncology .

Ocular Oncologists:
Dr. Farzad A. Jamshidi, MD, PhD – newly recruited Ocular Oncologist at UPMC

UPMC Vision Institute, led by José‑Alain Sahel, MD, combines the expertise of UPMC and the University of Pittsburgh Department of Ophthalmology to deliver world‑class eye care, pioneering research, and comprehensive education.

​

Since opening its flagship facility in the UPMC Mercy Pavilion in May 2023, the Vision Institute has provided over 410,000 sq ft of integrated clinical and research space, featuring its own clinical trials center, eight operating rooms, 83 exam rooms, and unmatched amenities such as a street‑simulation lab, rooftop sensory garden, and life‑skills apartment to support patient independence and rehabilitation

UPMC Visio Institute 1.jpg
UPMC Vision Institute logo_edited.jpg
Iowa HelathCare Eye Clinic 1.jpeg
Iowa HealthCare logo_edited.jpg
Ocular Oncologists:
Dr. Elaine B. Binkley, MD (Associate Professor, Retina and Ocular Oncology) 
Dr. H. Culver Boldt, MD is also on staff for ocular tumors

University of Iowa Health Care - Ophthalmology and Visual Sciences delivers nationally ranked, comprehensive eye care, from routine exams to the diagnosis and treatment of complex and rare eye diseases, including ocular cancers.

 

As one of the nation’s elite programs, with advanced clinics in cornea, glaucoma, retina, neuro-ophthalmology, inherited eye disease, uveitis, and low-vision rehabilitation, you’ll receive care from world-renowned specialists using cutting-edge diagnostics and therapies

Ocular Oncologists:
Dr. Vinit Mahajan, MD, PhD
Dr. Sophie J. Bakri, MD

At Mayo Clinic, world-class eye care meets compassionate innovation. Renowned for its excellence in diagnosing and treating complex eye diseases, Mayo Clinic Ophthalmology offers advanced care for retinal disorders, ocular cancers, and rare eye conditions.

 

Backed by cutting-edge research and a collaborative, patient-first approach, Mayo’s team of top specialists delivers personalized treatments that set national standards. When it comes to your vision, trust the name that’s synonymous with hope, healing, and excellence.

Mayo Clinic 1.jpg
Mayo Clinic Ophthalmology logo.jpg
midwest-eye-institute 1.jpg
MidWest Eye Institute logo.jpg
Ocular Oncologists:
Dr.  John Minturn

At Midwest Eye Institute, patients facing ocular and uveal melanoma receive expert, compassionate care from a team of highly skilled ophthalmologists and specialists. As a premier destination in the Midwest for eye cancer treatment, the Institute is dedicated to early diagnosis, personalized treatment planning, and long-term monitoring to achieve the best possible outcomes. With access to advanced diagnostic imaging, state-of-the-art radiation therapy (including plaque brachytherapy), and collaborative care involving retinal, oncology, and surgical experts, Midwest Eye Institute offers a comprehensive approach tailored to each patient’s unique case. The center combines clinical excellence with a patient-centered philosophy, providing not only world-class medical care but also emotional support and education throughout the journey.

Ocular Cancer | Eye Cancer

See the Light. Ocular Melanoma is Real | OcularCancer.com

Ocular Cancer | Eye Cancer
See the Light. Ocular Melanoma is Real | OcularCancer.com
See the Light. Ocular Melanoma is Real | OcularCancer.com
02:56

See the Light. Ocular Melanoma is Real | OcularCancer.com

Ocular Cancer | Eye Cancer
American Optometrict Association Eye Tech Vx 082324
01:31

American Optometrict Association Eye Tech Vx 082324

Ocular Cancer | Eye Cancer
Ocular Cancer Logo2.png

Your Journey. Your Story. Your Strength. 

Our Mission:
The Ocular Cancer Team is dedicated to raising awareness, advancing education, and empowering individuals impacted by rare eye cancers. We strive to promote early detection, support patients and caregivers, and advocate for research and treatment innovations - so that no one faces ocular cancer alone.

 

Our Goal:

To offers vital information, support, and resources for rare eye cancers - including ocular melanoma, retinoblastoma, conjunctival melanoma, and intraocular lymphoma - all in one place to empower patients and raise awareness.

  • Facebook
  • YouTube
  • Instagram
  • TikTok
See the Light. Ocular Melanoma is Real | OcularCancer.com
BlueOMBlack.org Facebook Group
Ocular Cancer Logo2.png

Launched 07.10.2025

​© MMXXV

​

OcularCancer.com

OcularCancer.org

Baby Blue Light Green Eye Cancer Awareness Ribbon.png
bottom of page